Zenosense (OTC: ZENO), through the development of MIDS
Cardiac™, seeks to provide a technology that delivers laboratory-level accuracy
at the point of care. An article discussing the company’s recent success reads:
“A successful development of MIDS Cardiac is just the first step in the
development of a wider technology platform that could be adapted to a wide
range of point of care immunoassay tests, based on the same concepts of speed,
accuracy, ease of use and cost-effectiveness. Zenosense and MIDS Medical
Limited are planning to use the platform to develop a multi-capability, highly
sensitive point of care device that could test for numerous conditions,
including prostate, colorectal and other cancers, inflammatory and autoimmune
disease, osteoporosis, endocrine ailments, blood infections, respiratory
viruses, meningitis, rheumatism, hepatitis, HIV, chlamydia and many more.”
To view the full article, visit http://ibn.fm/KTJq5
About Zenosense, Inc.
Zenosense Inc., through a joint-venture ownership in MIDS
Medical Ltd., is primarily focused on the development of a cost-effective,
hand-held Point of Care rapid cardiac diagnostic device, MIDS Cardiac. MIDS
Medical applies patent-protected magnetic nanoparticle detection technology and
a development team with world-class technical expertise. The MIDS Cardiac
device and test strip is being designed to support a variety of rapid high
sensitivity cardiac biomarker tests, with a focus on troponin I and T, to identify
or discount Acute Myocardial Infarction with accuracy equal or superior to high
sensitivity assays performed on laboratory analyzers. For more information,
visit the company’s website at www.ZenoSense.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment